'Clear cell rcc' presentation slideshows

Tumors of the Kidney and Urinary bladder

Tumors of the Kidney and Urinary bladder. Dr. Raid Jastania. Objectives. By the end of this session the student should be able to: List the common benign and malignant tumors of the kidney List the types of renal cell carcinoma Know the clinical presentation of Wilms tumor

1.12k views • 76 slides

526 views • 52 slides

526 views • 52 slides

Slide Seminar- IV Pathology of Renal Tumors

Slide Seminar- IV Pathology of Renal Tumors. Satish Tickoo Associate Prof. of Pathology Chief, Urologic Pathology Weill Medical College of Cornell University New York, NY. Slide Seminar- IV Pathology of Renal Tumors. Case 1: 55 years female with 3.5 cms well circumscribed left renal mass

735 views • 44 slides

Renal tumors

Renal tumors. Dr. Abdelaty Shawky Dr. Gehan Mohamed. 2. Papillary RCC. * Clinical Features: Comprises about 10% to 15% of all RCCs . More likely to be bilateral or multiple than other RCCs Significantly better outcome than that of the clear cell type. * Gross Pathology:

959 views • 25 slides

Renal tumors

Renal tumors. Dr. Abdelaty Shawky Dr. Gehan Mohamed. 2. Papillary RCC. * Clinical Features: Comprises about 10% to 15% of all RCCs . More likely to be bilateral or multiple than other RCCs Significantly better outcome than that of the clear cell type. * Gross Pathology:

360 views • 25 slides

Systemic treatment for non- clear cell histology Alessandra Mosca Medical Oncology

294 views • 23 slides

Basi molecolari delle terapie mirate nel carcinoma del rene metastatico Nicola Tinari

235 views • 23 slides

Introduction and Objectives

Material and Methods II Quantitative PCR (qPCR) RNA was reversely transcribed into cDNA (SuperScript II RNase H-Reverse Transcriptase, Invitrogen; random hexamer primers) qPCR using TaqMan Gene Expression Assays (Applied Biosystems):

240 views • 1 slides

Gene signatures of pulmonary renal cell carcinoma (RCC) metastases

206 views • 1 slides

PTTG1

Introduction and Objectives. Results of array analyses early vs. late Mets early Mets: PFS = 0 - 9 months, median = 1 month, n = 5 late Mets: PFS = 60-156 months, median = 92.5 months, n = 6 306 differentially expressed genes (414 probe sets; Fig.1), 27 ? & 279? in early Mets

262 views • 1 slides

Gene signatures of pulmonary renal cell carcinoma (RCC) metastases

Introduction and objectives patients (pts) with renal cell carcinoma (RCC) have a high risk of metastatic spread (up to 60% of the pts) ? urological cancer with the highest percentage of tumor-related deaths

151 views • 1 slides